Drug Shortage Report for APO-IRBESARTAN/HCTZ

Last updated on 2017-04-24 History
Report ID 345
Drug Identification Number 02387646
Brand name APO-IRBESARTAN/HCTZ
Common or Proper name IRBESARTAN/HCTZ
Company Name APOTEX INC
Active Ingredient(s) HYDROCHLOROTHIAZIDE IRBESARTAN
Strength(s) 12.5MG 150MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500 BTL
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2014-10-01
Estimated end date 2017-04-30
Actual end date 2017-04-21
Shortage status Resolved
Updated date 2017-04-24
Company comments APO-IRBESARTAN/HCTZ FCT 150/12.5MG100BTL is available
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2017-04-24 French Compare
v6 2017-04-24 English Compare
v5 2017-03-10 French Compare
v4 2017-03-10 English Compare
v3 2017-03-10 French Compare
v2 2017-03-10 French Compare
v1 2017-03-10 English Compare